Summary:
Crohn’s Disease Study Now Enrolling
GI Associates is currently enrolling a research study, assessing the safety and effectiveness of an investigational dose of an already approved, oral medication in Crohn’s disease.
Qualified Participants Must:
• Be 18 or older
•
Have active, moderate Crohn's disease
•
Be willing to attend up to 17 office visits over 57 weeks
*Other conditions may apply
Qualified Participants May Receive:
If you qualify, you will receive:
· Study-related drug at no cost
· Study-related medical exams at no cost
You may be compensated for time and travel